Phase I study of neoadjuvant 5-fluorouracil (5FU) chemoradiation (CRT) and trametinib in patients with locally advanced rectal cancers (LARC)

被引:1
|
作者
Wu, Christina Sing-Ying
Williams, Terence M.
Wei, Lai
Umar, Hamida
Mikhail, Sameh
Ciombor, Kristen Keon
Noonan, Anne M.
Roychowdhury, Sameek
El-Dika, Samer S.
Krishna, Somashekar
Upchurch, Bennie
McCarthy, Sean T.
Arnold, Mark
Harzman, Alan
Abdel-Misih, Sherif
Cirocco, William
Traugott, Amber
Bekaii-Saab, Tanios S.
Wuthrick, Evan John
机构
[1] Emory Univ, Atlanta, GA USA
[2] Ohio State Univ, James Canc Hosp, Comprehens Canc Ctr, Solove Res Inst, Columbus, OH USA
[3] Ohio State Univ, Arthur G James Canc Hosp, Comprehens Canc Ctr, Columbus, OH USA
[4] Ohio State Univ, Columbus, OH USA
[5] Mayo Clin, Scottsdale, AZ USA
关键词
D O I
10.1200/JCO.2017.35.4_suppl.685
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
685
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase Ⅱ study
    Zeynep Gural
    Sezer Saglam
    Serap Yucel
    Esra Kaytan-Saglam
    Oktar Asoglu
    Cetin Ordu
    Hediye Acun
    Rasul Sharifov
    Semen Onder
    Ahmet Kizir
    Ethem N Oral
    [J]. World Journal of Gastrointestinal Oncology, 2018, 10 (01) : 40 - 47
  • [32] CONTINUOUS 5-FLUOROURACIL (5FU) INFUSION IN CARCINOMA OF THE PANCREAS - A PHASE-II STUDY
    HANSEN, R
    QUEBBEMAN, E
    RITCH, P
    CHITAMBAR, C
    ANDERSON, T
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1988, 295 (02): : 91 - 93
  • [33] A phase II study of neoadjuvant gemcitabine/5-fluorouracil followed by 5-fluorouracil/oxaliplatin concurrent with radiation in patients with locally advanced pancreatic cancer.
    Lin, C.
    Kos, B. M.
    Sasson, A. R.
    Meza, J. L.
    Grem, J. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [34] PHARMACOKINETICS OF A NOVEL FORMULATION OF 5-FLUOROURACIL (5FU) AND LEUCOVORIN (LV): (DEFLEXIFOL) IN A PHASE I TRIAL
    Ackland, Stephen
    Garg, Madhu
    Ranson, Marie
    Jokela, Rebecca
    Reynolds, Gemma
    De Souza, Paul
    Clingan, Philip
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 21 - 22
  • [35] Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer
    Klautke, G
    Feyerherd, P
    Ludwig, K
    Prall, F
    Foitzik, T
    Fietkau, R
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (07) : 1215 - 1220
  • [36] Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer
    G Klautke
    P Feyerherd
    K Ludwig
    F Prall
    T Foitzik
    R Fietkau
    [J]. British Journal of Cancer, 2005, 92 : 1215 - 1220
  • [37] Erratum to: Kinetically Guided Neoadjuvant Chemoradiotherapy Based on 5-Fluorouracil in Patients with Locally Advanced Rectal Cancer
    Jiří Grim
    Miloš Hroch
    Jaroslav Chládek
    Jiří Petera
    Jiřina Martínková
    [J]. Clinical Pharmacokinetics, 2015, 54 (4) : 453 - 453
  • [38] The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature
    Anaïs Chauvin
    Chang-Shu Wang
    Sameh Geha
    Perrine Garde-Granger
    Alex-Ane Mathieu
    Vincent Lacasse
    François-Michel Boisvert
    [J]. Clinical Proteomics, 2018, 15
  • [39] The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature
    Chauvin, Anais
    Wang, Chang-Shu
    Geha, Sameh
    Garde-Granger, Perrine
    Mathieu, Alex-Ane
    Lacasse, Vincent
    Boisvert, Francois-Michel
    [J]. CLINICAL PROTEOMICS, 2018, 15
  • [40] Schedule dependency of 5-fluorouracil (5FU) chemotherapy in patients with advanced colorectal cancer: A systematic review\ .
    Barrajon, E
    Esquerdo, G
    Lopez, A
    Llorca, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 161S - 161S